BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.
about
Melioidosis: epidemiology, pathophysiology, and management.Animal models for Francisella tularensis and Burkholderia species: scientific and regulatory gaps toward approval of antibiotics under the FDA Animal RuleConsensus on the development of vaccines against naturally acquired melioidosisGlyburide reduces bacterial dissemination in a mouse model of melioidosisProphylactic application of CpG oligonucleotides augments the early host response and confers protection in acute melioidosisMelioidosis vaccines: a systematic review and appraisal of the potential to exploit biodefense vaccines for public health purposesStrategies toward vaccines against Burkholderia mallei and Burkholderia pseudomallei.Genomic characterization of Burkholderia pseudomallei isolates selected for medical countermeasures testing: comparative genomics associated with differential virulenceBurkholderia pseudomallei Rapidly Infects the Brain Stem and Spinal Cord via the Trigeminal Nerve after Intranasal Inoculation.Increased Neurotropic Threat from Burkholderia pseudomallei Strains with a B. mallei-like Variation in the bimA Motility Gene, AustraliaCharacterization of an autotransporter adhesin protein shared by Burkholderia mallei and Burkholderia pseudomallei.Melioidosis: Clinical impact and public health threat in the tropics.Genome wide transcriptome profiling of a murine acute melioidosis model reveals new insights into how Burkholderia pseudomallei overcomes host innate immunityDemonstrating the Protective Efficacy of the Novel Fluoroquinolone Finafloxacin against an Inhalational Exposure to Burkholderia pseudomallei.Distinct roles for nitric oxide in resistant C57BL/6 and susceptible BALB/c mice to control Burkholderia pseudomallei infectionGenetic control of weight loss during pneumonic Burkholderia pseudomallei infection.Cytokine gene expression in innately susceptible BALB/c mice and relatively resistant C57BL/6 mice during infection with virulent Burkholderia pseudomalleiDelineating the importance of serum opsonins and the bacterial capsule in affecting the uptake and killing of Burkholderia pseudomallei by murine neutrophils and macrophagesModel of differential susceptibility to mucosal Burkholderia pseudomallei infection.Pathogenicity of high-dose enteral inoculation of Burkholderia pseudomallei to mice.Mouse models of aerosol-acquired tularemia caused by Francisella tularensis types A and B.Oropharyngeal aspiration of Burkholderia mallei and Burkholderia pseudomallei in BALB/c mice.Novel Burkholderia mallei virulence factors linked to specific host-pathogen protein interactions.Evaluation of surrogate animal models of melioidosisLow-dose exposure of C57BL/6 mice to burkholderia pseudomallei mimics chronic human melioidosisA Burkholderia pseudomallei colony variant necessary for gastric colonizationGenome-wide expression analysis of Burkholderia pseudomallei infection in a hamster model of acute melioidosis.Combining vaccination and postexposure CpG therapy provides optimal protection against lethal sepsis in a biodefense model of human melioidosis.In vivo Bioluminescence Imaging of Burkholderia mallei Respiratory Infection and Treatment in the Mouse Model.Burkholderia pseudomallei type III secretion system cluster 3 ATPase BsaS, a chemotherapeutic target for small-molecule ATPase inhibitors.Role of inducible nitric oxide synthase and NADPH oxidase in early control of Burkholderia pseudomallei infection in mice.Development of vaccines against burkholderia pseudomallei.Peri-implant tissue is an important niche for Staphylococcus epidermidis in experimental biomaterial-associated infection in mice.Perturbation of the two-component signal transduction system, BprRS, results in attenuated virulence and motility defects in Burkholderia pseudomallei.Characterization of pathogenesis of and immune response to Burkholderia pseudomallei K96243 using both inhalational and intraperitoneal infection models in BALB/c and C57BL/6 mice.Immunostimulatory CpG oligodeoxynucleotide confers protection in a murine model of infection with Burkholderia pseudomallei.A non-invasive intratracheal inoculation method for the study of pulmonary melioidosisComparative genomics and an insect model rapidly identify novel virulence genes of Burkholderia malleiCharacterization of BcaA, a putative classical autotransporter protein in Burkholderia pseudomallei.Functional characterization of Burkholderia pseudomallei trimeric autotransporters.
P2860
Q24522461-4025E8B5-8174-4DDC-A0AC-DAF6083287ECQ26859041-795E1044-FB94-40DE-892E-B4298C1CE111Q26864912-0A22566E-3BF9-4E42-9012-210E9D6D56E7Q27305020-7F45838A-2925-472E-A6EC-1C308A486B7EQ27305350-8CA7262A-9FB8-4D29-9453-144DE48925A7Q27305733-E4245958-8D0F-416C-A1A2-8C5692D77920Q28299584-9EB96B1F-B3DB-4BC7-B54B-42FE4AAF6CEBQ28544928-7D850EF9-360A-47B9-A0A8-A998E3699773Q30803004-68937F9E-2D1C-4063-8752-B05ED6D18F96Q33597011-61281082-E6CB-4D52-A5B1-9B36917FF911Q33611911-952BAE63-D85D-4E8B-99AB-1C865059B3EDQ33663333-C303AB52-3113-47E7-A64E-369F2542A5EDQ33756790-14E4D678-02B3-4A1E-BA62-16DD8DAB4A6FQ33843665-44AA909E-1BC2-40D5-9EE7-9E324537334AQ33848546-9C1BBA9B-ADB6-43FF-A137-B228A7F7A42FQ33934354-421A3D71-7C2B-4655-9E35-ED6FB5289547Q34003899-450B2C1F-1D3E-4D70-9733-49F5087EF4B1Q34075114-DCC96623-6393-4E7C-A590-F3764690DFC2Q34116653-9AFFD622-960A-405E-A39E-61FAD0FF84F4Q34240068-D398B56C-EDFC-4FE8-87A7-3D905E8DEE05Q34539359-D5A723C9-816D-443B-B4C5-E873BAD34818Q34682080-90286FF0-65B9-40C3-B8BB-6C33CE036372Q34783879-252DA968-3196-4025-BE70-0BBF341F4932Q35028834-0B855D89-062B-45E9-91C1-7FB7E5D9E071Q35070115-C21A791A-43D6-4026-AF25-95B44EC51653Q35072333-AB7D6CE0-7244-438D-A4BD-4B0C4A307366Q35073824-523F7BC8-9BB1-49B6-B83E-285CE5A413BBQ35129390-878CDF79-6F02-469B-A0BA-6C873BD179FDQ35182600-B2C4D10A-A177-40EC-B938-3B8532EF5B73Q35187657-0A755C10-498E-43BB-A893-89867A135598Q35217529-73C53F39-C70F-41CF-927E-1C5B2E3AFB5DQ35234118-5F7BE157-8D1B-455C-8479-6780565D0669Q35689422-EF7053F2-9F21-475E-9EB2-CC929D98FFC9Q36008941-2EA9C908-DEFF-4AE2-8574-1D421019B3ABQ36289996-204FA547-9B8C-44BB-8242-00CCD177AC7EQ36445263-E7555A2F-9706-45B2-8664-AA69DB36F5C7Q36479077-DD0F48D5-B973-4878-A4D9-B1A7458FB939Q36540498-30031C42-474F-4C09-B93D-F73820018D26Q36804742-D355BC8B-CA26-4C78-A8AC-12FB156132A0Q37035962-C32711B4-90CB-4C24-8807-0B695CAF5B8D
P2860
BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis.
description
1998 nî lūn-bûn
@nan
1998年の論文
@ja
1998年学术文章
@wuu
1998年学术文章
@zh-cn
1998年学术文章
@zh-hans
1998年学术文章
@zh-my
1998年学术文章
@zh-sg
1998年學術文章
@yue
1998年學術文章
@zh
1998年學術文章
@zh-hant
name
BALB/c and C57Bl/6 mice infect ...... ic forms of human melioidosis.
@en
BALB/c and C57Bl/6 mice infect ...... ic forms of human melioidosis.
@nl
type
label
BALB/c and C57Bl/6 mice infect ...... ic forms of human melioidosis.
@en
BALB/c and C57Bl/6 mice infect ...... ic forms of human melioidosis.
@nl
prefLabel
BALB/c and C57Bl/6 mice infect ...... ic forms of human melioidosis.
@en
BALB/c and C57Bl/6 mice infect ...... ic forms of human melioidosis.
@nl
P356
P1476
BALB/c and C57Bl/6 mice infect ...... ic forms of human melioidosis.
@en
P2093
P304
P356
10.1006/MPAT.1997.0179
P50
P577
1998-05-01T00:00:00Z